UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

COMPARISON OF THE EFFECTIVENESS OF AN INTEGRATED THERAPEUTIC STRATEGY FOR OPIOID DEPENDENCE INCLUDING PSYCHOLOGICAL AND PSYCHOTHERAPEUTIC INTERVENTIONS VERSUS OPIOID AGONIST MONOTHERAPY

Type of Article

In the Section

Index UDK:

Abstract

Pediatric-onset multiple sclerosis (POMS) is a rare but significant neurological condition that poses a considerable threat to children’s health. Compared to adult-onset multiple sclerosis (AOMS), POMS is characterized by distinct clinical and pathophysiological features. Quality of life (QoL) is a crucial indicator of overall well-being in children with MS; however, its relationship with objective neurobiological markers — such as brain volumetric parameters — remains insufficiently explored in the pediatric population. This study aimed to examine the correlations between brain volumetric indices and QoL scores, as assessed by the PedsQL 4.0 questionnaire, in a cohort of children diagnosed with MS

The study included 39 pediatric MS patients. Spearman’s rank correlation coefficient (R) was used to analyze the associations between subjective QoL assessments and objective MRI‑derived brain volumetric data. Significant correlations were observed between self-reported QoL scores and the volumes of key brain structures. Notably, a strong positive correlation was found with thalamic volume (up to R = 0.55). In contrast, proxy-reported QoL scores provided by parents showed no significant correlations with any of the examined volumetric parameters. These findings highlight the potential role of thalamic volumetry as a morphometric biomarker of disease progression that aligns with the patient’s subjective experience of their condition. Despite the discrepancy between child and parent reports, we emphasize the importance of integrating both perspectives to ensure a comprehensive assessment of the patient’s status in clinical practice and future research.

Pages

References

  1. Clivlend Clinic, Neurological Institute. Pediatric-Onset Multiple Sclerosis. https://my.clevelandclinic.org/departments/neurological/depts/multiple-sclerosis/ms-approaches/pediatriconset-multiple-sclerosis
  2. Waldman A, Ness J, Pohl D, et al. Pediatric multiple sclerosis: Clinical features and outcome. Neurology. 2016;87(9 Suppl 2):S74- S81. doi:https://doi.org/1212/WNL.0000000000003028
  3. Hacohen Y, Eshaghi A. Multiple Sclerosis in Children and Adults: Does Age Matter?. Neurology. 2021;97(20):929-930 doi:https://doi.org/1212/WNL.0000000000012866
  4. Mastorci F, Lazzeri MFL, Ait-Ali L, Festa P, Pingitore A. Chronic Disease in Pediatric Population—A Narrative Review of Psychosocial Dimensions and Strategies for Management. Children. 2025; 12(8):967. https://doi.org/10.3390/children12080967
  5. Pinquart M. Health-Related Quality of Life of Young People With and Without Chronic Conditions. J Pediatr Psychol. 2020;45(7):780-792. doi:https://doi.org/1093/jpepsy/jsaa052
  6. Ekmekci O. Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features. Behav Neurol. 2017;2017:1463570. doi:https://doi.org/1155/2017/1463570. 2017:1463570. doi: https://doi.org/10.1155/2017/1463570
  7. Tarantino S, Proietti Checchi M, Papetti L, Monte G, Ferilli MAN, Valeriani M. Neuropsychological performances, quality of life, and psychological issues in pediatric onset multiple sclerosis: a narrative review. Neurol Sci. 2024;45(5):1913-1930. doi:https://doi.org/1007/s10072-023-07281-y
  8. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800-812. doi: https://doi.org/10.1097/00005650-200108000-00006
  9. Brune S, Høgestøl EA, Cengija V, et al. LesionQuant for Assessment of MRI in Multiple Sclerosis-A Promising Supplement to the Visual Scan Inspection. Front Neurol. 2020;11:546744. Published 2020 Dec 11. doi: https://doi.org/10.3389/fneur.2020.546744
  10. Marek J, Bachurska D, Wolak T, Borowiec A, Sajdek M, Maj E. Quantitative brain volumetry in neurological disorders: from disease mechanisms to software solutions. Pol J Radiol. 2025;90:e299-e306. Published 2025 Jun 11. doi: https://doi.org/5114/ pjr/203781
  11. The Role of Volumetric Neuroimaging in the Evaluation of Multiple Sclerosis. March 31, 2016. https://www.cortechs.ai/volumetric-neuroimaging-ms
  12. Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis. J Neuroimaging. 2018;28(5):490-495. doi: https://doi.org/10.1111/jon.12527
  13. Brain volume changes may be key indicator for MS progression. Last updated: 15th June 2018. https://www.msif.org/news/2018/06/15/brain-volume-changes-may-be-keyindicator-for-ms-progression/
  14. Varni JW. The PedsQL. Measurement Model for the Pediatric Quality of Life Invertory. About the Model. https://www.pedsql.org/about_pedsql.html
  15. Varni JW. The PedsQL. Measurement Model for the Pediatric Quality of Life Invertory. Newsletter. https://www.pedsql.org/pedsql2.html
  16. Sattoe JN, van Staa A, Moll HA; On Your Own Feet Research Group. The proxy problem anatomized: child-parent disagreement in health related quality of life reports of chronically ill adolescents. Health Qual Life Outcomes. 2012;10:10. Published 2012 Jan 25. doi:https://doi.org/1186/1477-7525-10-10
  17. Lam W, Ngai FW, Chan KYY, et al. Agreement Between Child Self-Report With Parent Proxy Report on the Quality of Life of Children With Medical Complexity: A Cross-Sectional Study. Nurs Health Sci. 2025;27(2):e70103. doi:https://doi.org/1111/nhs.70103
  18. Armin M, Daniel Ontaneda D. Thalamic Injury and Cognition in Multiple Sclerosis. Front Neurol. 202;11:623914. Published 2021 Feb 5. doi:https://doi.org/3389/fneur.2020.623914
  19. Koubiyr I, Krijnen EA, Eijlers AJC et al. Longitudinal fibre-specific white matter damage predicts cognitive decline in multiple sclerosis. Brain Commun. 2024;6(1):fcae018. Published 2024 Jan 27. doi:https://doi.org/1093/braincomms/fcae018
  20. Hulst HE, Steenwijk MD, Versteeg A, et al. Cognitive impairment in MS Impact of white matter integrity, gray matter volume, and lesions. Neurology. 2013;80 (11) :1025-1032 doi: https://doi.org/10.1212/WNL.0b013e31828726cc